{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:25:15Z","timestamp":1783700715248,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2019B030316023"],"award-info":[{"award-number":["2019B030316023"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["SL2022A03J00860"],"award-info":[{"award-number":["SL2022A03J00860"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Placenta accreta spectrum (PAS) disorder is a major cause of postpartum hemorrhage-associated maternal and fetal death, and novel methods for PAS screening are urgently needed for clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The purpose of this study was to develop new methods for PAS screening using serum biomarkers and clinical indicators. A total of 95 PAS cases and 137 controls were enrolled in a case\u2013control study as cohort one, and 44 PAS cases and 35 controls in a prospective nested case\u2013control study were enrolled as cohort two. All subjects were pregnant women of Chinese Han population. Biomarkers for PAS from maternal blood samples were screened based on high-throughput immunoassay and were further validated in three phases of cohort one. Screening models for PAS were generated using maternal serum biomarkers and clinical indicators, and were validated in two cohorts. The expression levels of biomarkers were analyzed using histopathological and immunohistochemical (IHC) techniques, and gene expression was examined by QPCR in the human placenta. Binary logistic regression models were built, and the area under the curve (AUC), sensitivity, specificity, and Youden index were calculated. Statistical analyses and model building were performed in SPSS and graphs were generated in GraphPad Prism. The independent-sample\n                      <jats:italic>t<\/jats:italic>\n                      test was used to compare numerical data between two groups. For nonparametric variables, a Mann\u2013Whitney\n                      <jats:italic>U<\/jats:italic>\n                      test or a\n                      <jats:italic>X<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      test was used.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results demonstrated that the serum levels of matrix metalloproteinase-1 (MMP-1), epidermal growth factor (EGF), and vascular endothelial growth factor-A (VEGF-A) were consistently higher, while the level of tissue-type plasminogen activator (tPA) was significantly lower in PAS patients compared with normal term controls and patients with pre-eclampsia (PE) and placenta previa (PP). IHC and QPCR analysis confirmed that the expression of the identified biomarkers significantly changed during the third trimester in human placenta. The generated screening model combining serum biomarkers and clinical indicators detected 87% of PAS cases with AUC of 0.94.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum biomarkers can be used for PAS screening with low expense and high clinical performance; therefore, it may help to develop a practicable method for clinical prenatal PAS screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-023-05784-2","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T04:02:16Z","timestamp":1689048136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators:\u00a0a case\u2013control study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiayi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingneng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"issue":"11","key":"5784_CR1","first-page":"1795","volume":"29","author":"WA Goh","year":"2015","unstructured":"Goh WA, Zalud I. Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta. J Matern Fetal Neonatal Med. 2015;29(11):1795\u2013800.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"5784_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0002-9378(16)34741-X","volume":"95","author":"RK Luke","year":"1966","unstructured":"Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966;95(5):660\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"5784_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajog.2019.01.233","volume":"221","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Bunce C, Gronbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2019;221(3):208\u201318.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"5784_CR4","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","volume":"192","author":"S Wu","year":"2005","unstructured":"Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458\u201361.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5784_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejogrb.2013.08.030","volume":"171","author":"MF Higgins","year":"2013","unstructured":"Higgins MF, Monteith C, Foley M, O\u2019Herlihy C. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 2013;171(1):54\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"5784_CR6","first-page":"74","volume":"15","author":"Z Jianmei","year":"2014","unstructured":"Jianmei Z, Xiaoru Yi, Hongqing J. Logistic regression analysis on risk factors of placenta accreta occurs on puerpera. Chin Med Record (Chinese). 2014;15(5):74\u20136.","journal-title":"Chin Med Record (Chinese)"},{"issue":"3","key":"5784_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ijgo.12408","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274\u201380.","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"5784_CR8","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/1471-0528.13547","volume":"123","author":"L Thurn","year":"2015","unstructured":"Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadottir RI, Tapper AM, Bordahl PE, Gottvall K, Petersen KB, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2015;123(8):1348\u201355.","journal-title":"BJOG"},{"issue":"4","key":"5784_CR9","first-page":"693","volume":"80","author":"C Zelop","year":"1992","unstructured":"Zelop C, Nadel A, Frigoletto FD Jr, Pauker S, MacMillan M, Benacerraf BR. Placenta accreta\/percreta\/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol. 1992;80(4):693\u20134.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"5784_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/pd.4277","volume":"34","author":"N Desai","year":"2013","unstructured":"Desai N, Krantz D, Roman A, Fleischer A, Boulis S, Rochelson B. Elevated first trimester PAPP\u2013a is associated with increased risk of placenta accreta. Prenat Diagn. 2013;34(2):159\u201362.","journal-title":"Prenat Diagn"},{"issue":"24","key":"5784_CR11","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3109\/14767058.2016.1152576","volume":"29","author":"AO Ersoy","year":"2016","unstructured":"Ersoy AO, Oztas E, Ozler S, Ersoy E, Erkenekli K, Uygur D, Caglar AT, Danisman N. Can venous ProBNP levels predict placenta accreta? J Matern Fetal Neonatal Med. 2016;29(24):4020\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"5784_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.placenta.2014.07.007","volume":"35","author":"J Zhou","year":"2014","unstructured":"Zhou J, Li J, Yan P, Ye YH, Peng W, Wang S, Wang XT. Maternal plasma levels of cell-free beta-HCG mRNA as a prenatal diagnostic indicator of placenta accrete. Placenta. 2014;35(9):691\u20135.","journal-title":"Placenta"},{"issue":"1","key":"5784_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijgo.2009.11.013","volume":"109","author":"MM El Behery","year":"2010","unstructured":"El Behery MM, Rasha LE, El Alfy Y. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynaecol Obstet. 2010;109(1):30\u20133.","journal-title":"Int J Gynaecol Obstet"},{"key":"5784_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2016.01.004","volume":"39","author":"E Oztas","year":"2016","unstructured":"Oztas E, Ozler S, Ersoy AO, Ersoy E, Caglar AT, Uygur D, Yucel A, Ergin M, Danisman N. Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta. Placenta. 2016;39:1\u20136.","journal-title":"Placenta"},{"issue":"1","key":"5784_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4274\/balkanmedj.2016.1890","volume":"35","author":"H Uyanikoglu","year":"2017","unstructured":"Uyanikoglu H, Incebiyik A, Turp AB, Cakmak G, Sak S, Hilali NG. Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta. Balkan Med J. 2017;35(1):55\u201360.","journal-title":"Balkan Med J"},{"issue":"3","key":"5784_CR16","doi-asserted-by":"publisher","first-page":"433.e1","DOI":"10.1016\/j.ajog.2020.03.019","volume":"223","author":"SA Shainker","year":"2020","unstructured":"Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, Dalton ME, Otu HH, et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol. 2020;223(3):433.e1-433.e14.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5784_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s43032-020-00319-y","volume":"28","author":"A Schwickert","year":"2020","unstructured":"Schwickert A, Chantraine F, Ehrlich L, Henrich W, Muallem MZ, Nonnenmacher A, Petit P, Weizsacker K, Braun T. Maternal serum VEGF predicts abnormally invasive placenta better than NT-proBNP: a multicenter case-control study. Reprod Sci. 2020;28(2):361\u201370.","journal-title":"Reprod Sci"},{"key":"5784_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.placenta.2020.01.007","volume":"91","author":"A Al-Khan","year":"2020","unstructured":"Al-Khan A, Youssef YH, Feldman KM, Illsley NP, Remache Y, Alvarez-Perez J, Mannion C, Alvarez M, Zamudio S. Biomarkers of abnormally invasive placenta. Placenta. 2020;91:37\u201342.","journal-title":"Placenta"},{"issue":"1","key":"5784_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ijgo.12761","volume":"146","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3\u20134","key":"5784_CR20","first-page":"e137","volume":"5","author":"JY Zhu","year":"2012","unstructured":"Zhu JY, Pang ZJ, Yu YH. Regulation of trophoblast invasion: the role of matrix metalloproteinases. Rev Obstet Gynecol. 2012;5(3\u20134):e137-143.","journal-title":"Rev Obstet Gynecol"},{"issue":"5","key":"5784_CR21","first-page":"311","volume":"41","author":"Y Ke","year":"2006","unstructured":"Ke Y, Lu JH, Yang BL, Guo HQ, Ma QY, Zhu H, Shu HM, Li DJ. Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta. Zhonghua Fu Chan Ke Za Zhi. 2006;41(5):311\u20134.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"5784_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7827-12-7","volume":"12","author":"AU Borbely","year":"2014","unstructured":"Borbely AU, Sandri S, Fernandes IR, Prado KM, Cardoso EC, Correa-Silva S, Albuquerque R, Knofler M, Beltrao-Braga P, Campa A, et al. The term basal plate of the human placenta as a source of functional extravillous trophoblast cells. Reprod Biol Endocrinol. 2014;12:7.","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"5784_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/ijms18081651","volume":"18","author":"Y Ye","year":"2017","unstructured":"Ye Y, Vattai A, Zhang X, Zhu J, Thaler CJ, Mahner S, Jeschke U, von Schonfeldt V. Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases. Int J Mol Sci. 2017;18(8):1651.","journal-title":"Int J Mol Sci"},{"issue":"31","key":"5784_CR24","doi-asserted-by":"publisher","first-page":"eaat6114","DOI":"10.1126\/sciimmunol.aat6114","volume":"4","author":"SE Ander","year":"2019","unstructured":"Ander SE, Diamond MS, Coyne CB. Immune responses at the maternal-fetal interface. Sci Immunol. 2019;4(31):eaat6114.","journal-title":"Sci Immunol"},{"issue":"1","key":"5784_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/plac.2001.0738","volume":"23","author":"P Georgiades","year":"2002","unstructured":"Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta. 2002;23(1):3\u201319.","journal-title":"Placenta"},{"issue":"5","key":"5784_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/uog.13194","volume":"42","author":"F D'Antonio","year":"2013","unstructured":"D\u2019Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42(5):509\u201317.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"5784_CR27","first-page":"55","volume":"75","author":"R Dig","year":"2021","unstructured":"Dig R, Buca D, Galliani C, D\u2019Amico A, CA G, Lucidi A, Giannini C, Chiarelli F, Liberati M, D\u2019Antonio F. Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology. Minerva Obstet Gynecol. 2021;75(1):55\u201361.","journal-title":"Minerva Obstet Gynecol"},{"issue":"25","key":"5784_CR28","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1080\/14767058.2021.2005568","volume":"35","author":"G Cali","year":"2022","unstructured":"Cali G, Labate F, Cucinella G, Fabio M, Buca D, Di Girolamo R, Khalil A, D\u2019Antonio F. Placenta accreta spectrum disorders in twin pregnancies as an under reported clinical entity: a case series and systematic review. J Matern Fetal Neonatal Med. 2022;35(25):8848\u201351.","journal-title":"J Matern Fetal Neonatal Med"}],"updated-by":[{"DOI":"10.1186\/s12884-026-09053-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000}}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-05784-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:26:22Z","timestamp":1778480782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-023-05784-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5784"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-05784-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the authors identified an error in Fig. 4. The correct figure is given below. The original article has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12884-026-09053-w","URL":"https:\/\/doi.org\/10.1186\/s12884-026-09053-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval (No. 2014[085], approval date August 2014) of the Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University. The research was carried out according to the Declaration of Helsinki, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"508"}}